Company intelligence
European Medicines Agency
The mission of EMA is to foster scientific excellence in the evaluation and supervision of medicines in the EU.
About European Medicines Agency
The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.
Verified activity
Signals from European Medicines Agency
8 published signals
Research & Knowledge
European Medicines Agency commissioned studies through DARWIN EU® to generate real-world evidence to improve understanding of women's health and where information from clinical trials is too limited.
Reported by European Medicines Agency
Presence & Recognition
European Medicines Agency is hosting a workshop on women's health broadcast live on 28 and 29 September 2026.
Reported by European Medicines Agency
Research & Knowledge
European Medicines Agency safety committee PRAC started a review of injectable iron-containing medicines following concerns about low phosphate levels in the blood and related bone problems.
Reported by European Medicines Agency
Legal & Regulatory
European Medicines Agency announced a new EU supply chain to end the shortage of Visudyne, a medicine used to treat adults with certain serious eye conditions, with full restoration expected in 2027.
Reported by European Medicines Agency
People
European Medicines Agency is currently recruiting trainees across a range of exciting areas
Reported by European Medicines Agency
Presence & Recognition
European Medicines Agency welcomed Ambassador H.E. Ann Derwin during Ireland's Presidency of the Council of the European Union.
Reported by European Medicines Agency
Research & Knowledge
European Medicines Agency launched a new voluntary data submission pilot to advance innovative alternatives to animal testing, enabling developers to submit data generated using new approach methodologies and receive tailored scientific feedback.
Reported by European Medicines Agency
Research & Knowledge
European Medicines Agency published a guest article authored by Evdokia Korakianiti, the Head of Quality and Safety Department, discussing a pilot that allows regulators to review company submissions simultaneously when important manufacturing changes are made after a medicine was approved.
Reported by European Medicines Agency